title: Are the antiarrhythmic-defibrillating effects of D-sotalol due to or despite the prolongation of the action potential duration?
abstract: These results support our hypothesis that class III compounds, with a positive inotropic effect, increase intercellular coupling and synchronization, mainly by preventing intracellular Ca overload. They act as defibrillating compound, similar to cAMP and adrenaline, most probably due to their so called sympathomimetic effect. In our opinion, their cardioprotective effects, resembling cardioversion, are not related to their ability to prolong APD and ERP. Moreover, we suggest that any compound that possesses these sympathomimetic effects, but without inducing the arrhythmogenic prolongation of APD, may exhibit a potent, safety and more efficient antiarrhythmic - defibrillating ability.
authors.forename: M
authors.initials: M
authors.lastname: Manoach
authors.forename: D
authors.initials: D
authors.lastname: Varon
authors.forename: N
authors.initials: N
authors.lastname: Tribulova
authors.forename: A
authors.initials: A
authors.lastname: Shainberg
authors.forename: T
authors.initials: T
authors.lastname: Zinman
authors.forename: A
authors.initials: A
authors.lastname: Isaack
authors.forename: I
authors.initials: I
authors.lastname: Imanaga
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002316:Cardiotonic Agents / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D013015:Sotalol / Q000494:pharmacology*; D013237:Stereoisomerism; D014693:Ventricular Fibrillation / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D013015:Sotalol